Latest Options News

Raptor Metals Ltd has completed its takeover of Raptor Resources Limited, marking a strategic pivot to copper exploration in Canada’s Bathurst Mining Camp, backed by a fresh A$5 million capital raise.

Larvotto Resources is on track for mid-2026 production at its Hillgrove Antimony-Gold Project, backed by robust drilling results, plant refurbishment progress, and promising tungsten recovery. The company also expands its copper portfolio with a strategic option on the Blockade Mine in Mt Isa.

Southern Palladium has made significant strides in advancing its Bengwenyama platinum group metals project, completing key drilling and regulatory milestones while securing A$20 million in fresh capital to fund the next development phase.

Cobalt Blue Holdings has enhanced the financial outlook for its Kwinana Cobalt Refinery project, secured a $5.3 million capital raise, and advanced key environmental and feedstock initiatives amid a tightening cobalt market.

ReNerve Limited reported a robust 80% increase in quarterly sales driven by strong US market adoption and expanded hospital approvals. The company advances its nerve repair product pipeline with key regulatory milestones and a refreshed board.

Great Boulder Resources has hit a major milestone with a 1.02 million ounce gold resource at its Side Well project, backed by a record 34,000 metres of drilling in the December quarter. The company’s strong cash position and ongoing exploration signal further growth potential.

Terra Critical Minerals has completed a key acquisition in Nevada and boosted its Canadian uranium investment, positioning itself to capitalise on soaring tungsten and uranium prices.

Cosmo Metals has completed its first drilling program at Spring Creek in NSW after nearly 30 years, revealing high-grade gold mineralisation and identifying a new antimony-rich corridor, supported by government grants to advance exploration.

Native Mineral Resources reported steady gold production at its Blackjack operations, completed key plant upgrades, and progressed joint ventures, supported by a $3 million convertible note raise.

Biotron Limited has successfully closed its fully subscribed rights issue, raising $1.52 million, and completed the acquisition of Sedarex Limited, positioning itself for growth in its diversified biotech portfolio.

Alterity Therapeutics has bolstered its Phase 2 data for ATH434 in Multiple System Atrophy and is advancing regulatory plans for a pivotal Phase 3 trial, supported by a robust cash position of A$49.2 million.

Antares Metals has strategically acquired two Western Australian gold and copper projects while uncovering a significant high-grade copper zone at its Mt Isa North project, backed by a $2 million capital raise and new leadership.